Table 3 Univariate and Multivariate analysis of potential molecular markers for overall survival of hepatoblastoma

Preoperative chemotherapy

   (yes versus no)

1.36(0.89-3.79)

0.046

2.16(0.91-5.11)

0.074

surgical resection

   (yes versus no)

1.81(0.92-3.62)

0.082

2.13(1.17-4.43)

0.033

Gli1 expression

   (positive versus negative)

4.75(1.16-15.61)

0.011

6.34(1.35-18.86)

0.007

Patched expression

   (positive versus negative)

2.53(0.81-5.86)

0.161

3.12(0.93-6.45)

0.084